Choosing a country will allow you to access local content and enable you to shop in your local currency.
Worldwide demand for biopharmaceuticals is increasing dramatically. This requires a new strategy to meet this growing need.
KUBio biomanufacturing solution is that strategy. KUBio creates biomanufacturing capacity by delivering a fully functional, ready-to-run facility in 14-18 months. Predesigned to meet cGMP requirements, KUBio helps biopharmaceutical manufacturers respond rapidly to local healthcare needs. KUBio also supports global biomanufacturers in bringing life-saving treatments to market more quickly.
KUBio biomanufacturing solution is one component of GE’s Enterprise Solutions. KUBio consists of prefabricated modules equipped with the heating, ventilating, air conditioning (HVAC) system and all the piping necessary to run a biomanufacturing plant. The facility can be equipped with an integrated FlexFactory single-use manufacturing platform, or a hybrid processing platform.
The other components of Enterprise Solutions include:
KUBio is equipped with the FlexFactory biomanufacturing platform which reduces operational costs by enabling faster deployment, accelerated production turnaround, multiproduct processing, and scalable production.
KUBio modular units provide a fully-functional bioprocessing facility designed to deliver a rapid response to local healthcare requirements:
In addition, we provide a range of services that complement the specific needs of your project in process development, clinical material, bioprocess training, and financing solutions.
GE Healthcare is a well-established and financially stable organization owned by General Electric Company. Our presence in more than 100 countries, know-how, and partnerships with industry-leading suppliers bring expertise to every step of your manufacturing project.
For complete peace of mind, we manage every aspect of your KUBio project from offsite prefabrication to onsite equipment start-up and ensure your investment is fixed and known from the start.
We've detected that you're using an unsupported browser.You may continue browsing, but for the best experience, please use Mozilla Firefox (v.30+), Google Chrome (v.35+) or Internet Explorer (v.11+).